---
title: "CELLERON THERAPEUTICS LIMITED — Ownership Dossier"
canonical: https://whiteintel.dev/entity/c486cb95-4643-5ccc-877b-950c57ff1877
json: https://whiteintel.dev/api/public/dossier/c486cb95-4643-5ccc-877b-950c57ff1877
identifier: oo:GB-COH-05162047
jurisdiction: GB
risk: Low
source: WhiteIntel corporate-ownership graph
---

# CELLERON THERAPEUTICS LIMITED

**Type:** Company  
**Jurisdiction:** [GB](https://whiteintel.dev/jurisdictions/gb)  
**Identifier:** `oo:GB-COH-05162047`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/c486cb95-4643-5ccc-877b-950c57ff1877  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/c486cb95-4643-5ccc-877b-950c57ff1877  

## Ownership & control

### Owners / controllers

- **INGENOX THERAPEUTICS LIMITED** (beneficial owner) — 100% — https://whiteintel.dev/entity/45a779f7-29fc-5fea-94b7-9d53892025f6
- **Prof Nicholas Barrie La Thangue** (beneficial owner) — 50% — https://whiteintel.dev/entity/9c51d6b8-1fd4-5a5a-a550-4a6f333398cc
- **INGENOX THERAPEUTICS LIMITED** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/45a779f7-29fc-5fea-94b7-9d53892025f6
- **Prof Nicholas Barrie La Thangue** (beneficial owner) — 37.5% — https://whiteintel.dev/entity/f2fed2da-532e-4cee-b109-80926ba9083b

### UBO chain (walk to the ultimate owner)

A **7-step** ownership/control chain to the ultimate beneficial owner is resolved for this entity. The full cited chain unlocks with a paid API key or a one-off dossier — https://whiteintel.dev/pricing.

## Company profile (live · UK Companies House)

- **Company number:** `05162047`
- **Status:** active
- **Type:** ltd
- **Incorporated:** 2004-06-24
- **Registered office:** Magdalen Centre Robert Robinson Avenue, Oxford Science Park, Oxford, OX4 4GA, England
- **SIC:** 72110

### Officers

- LA THANGUE, Nicholas Barrie, Prof — director · British · appointed 2004-06-24
- MCDONALD, Douglas Fraser — secretary · British · appointed 2009-04-17 · resigned 2022-12-22
- WCPHD SECRETARIES LIMITED — corporate secretary · appointed 2004-06-24 · resigned 2009-04-17
- CHUN, Ji Woong — director · South Korean · appointed 2016-12-16 · resigned 2021-11-23
- FLEMING, William John Robert — director · British · appointed 2021-08-16 · resigned 2024-09-18
- INNES-KER, Katherine, Dr — director · British · appointed 2021-09-13 · resigned 2022-03-24
- KERR, David James, Prof — director · British · appointed 2011-09-30 · resigned 2023-02-21
- KERR, David James, Professor — director · British · appointed 2005-03-09 · resigned 2011-02-18
- LEE, Sangwoo — director · South Korean · appointed 2016-09-23 · resigned 2022-12-22
- MANION, Doug — director · American,Canadian · appointed 2017-05-17 · resigned 2021-08-31
- NOBLE, James Julian — director · British · appointed 2019-10-22 · resigned 2023-02-21
- TAYLOR, Richard Kirby — director · British · appointed 2021-09-13 · resigned 2023-02-21
- WHITTAKER, Frederick John, Dr — director · British · appointed 2012-10-01 · resigned 2017-05-17
- WILLIAMS, Robert John, Dr — director · British · appointed 2004-06-24 · resigned 2005-03-09

### Beneficial owners (Persons with Significant Control)

- [Ingenox Therapeutics Limited](https://whiteintel.dev/entity/45a779f7-29fc-5fea-94b7-9d53892025f6) — 75–100% shares · corporate PSC · United Kingdom — since 2022-12-22
- Prof Nicholas Barrie La Thangue — 25–50% shares · individual PSC · England — ceased 2022-12-22

## Provenance

- companies_house_bulk — https://find-and-update.company-information.service.gov.uk/company/05162047
- OpenOwnership — https://find-and-update.company-information.service.gov.uk/company/05162047

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **CELLERON THERAPEUTICS LIMITED**. Human view: https://whiteintel.dev/entity/c486cb95-4643-5ccc-877b-950c57ff1877 · Structured JSON: https://whiteintel.dev/api/public/dossier/c486cb95-4643-5ccc-877b-950c57ff1877._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._